UBS AM’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.2M | Buy |
942,851
+126,261
| +15% | +$2.3M | ﹤0.01% | 1111 |
|
|
2025
Q1 | $16.2M | Buy |
816,590
+305,064
| +60% | +$6.05M | ﹤0.01% | 1042 |
|
|
2024
Q4 | $8.77M | Buy |
511,526
+1,559
| +0.3% | +$26.7K | ﹤0.01% | 1313 |
|
|
2024
Q3 | $10.2M | Sell |
509,967
-26,020
| -5% | -$520K | ﹤0.01% | 1206 |
|
|
2024
Q2 | $5.99M | Buy |
535,987
+316,700
| +144% | +$3.54M | ﹤0.01% | 1393 |
|
|
2024
Q1 | $1.45M | Buy |
219,287
+32,090
| +17% | +$212K | ﹤0.01% | 1835 |
|
|
2023
Q4 | $846K | Buy |
187,197
+20,569
| +12% | +$93K | ﹤0.01% | 2117 |
|
|
2023
Q3 | $597K | Buy |
166,628
+28,500
| +21% | +$102K | ﹤0.01% | 2222 |
|
|
2023
Q2 | $457K | Hold |
138,128
| – | – | ﹤0.01% | 2361 |
|
|
2023
Q1 | $457K | Buy |
+138,128
| New | +$457K | ﹤0.01% | 2361 |
|